BATF3 and neoplasm: Indeed, Batf3−/− mice are unable to reject highly immunogenic tumors due to defective cross-presentation by Batf3−/− DC, reduced tumor-infiltration of CD8+ T cells and failure to develop tumor-specific CTL (8).